Key facts
- SweetBio’s last known valuation is $15.0M (Jan 2021).
- It has raised $8.3M across 4 recorded rounds; the latest was Seed Round ($590K) in Oct 2020.
- Notable investors include Springboard Enterprises, Launch Tennessee, InvestTN, 1945 Capital, Apple — 12 tracked in total.
- SweetBio has filed 8 Form Ds with the SEC since 2015, most recently Apr 2024 ( sold).
- Status: Privately Held (backing).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for SweetBio
Create free account
No card required
Funding rounds
4 roundsJan 2019Accelerator/Incubator—▮
About SweetBio
Developer of wound care products designed to aid the healing of non-healing wounds. The company offers honey-based dressings that are simple to apply and reduce residue, enabling patients and caregivers to manage wound care with less complexity.
- Industry
- Medical Supplies
- Sector
- Healthcare
- HQ
- Memphis, TN, United States
- Founded
- 2015
- Employees
- 10
- Website
- sweetbio.com/
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
SweetBio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in SweetBio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on SweetBio in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.